We are live on ! Find out more
VIVE

VIVEVE MED INC
VIVE

Delisted

VIVE was delisted on the 18th of January, 2023.

Back to rankings

15 hedge funds and large institutions have $1.89M invested in VIVEVE MED INC in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.01% more ownership

Funds ownership: 6.04% → 6.04% (+0.01%)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

1% less capital invested

Capital invested by funds: $1.91M → $1.89M (-$15K)

12% less funds holding

Funds holding: 17 → 15 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
+$154K
2
Goldman Sachs
Goldman Sachs
New York
+$134K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$80.6K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$56.3K
5
Northern Trust
Northern Trust
Illinois
+$51.1K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$154K
2
VF
Virtu Financial
New York
-$132K
3
Jane Street
Jane Street
New York
-$53K
4
UBS Group
UBS Group
Switzerland
-$43.9K
5
EGM
Engineers Gate Manager
New York
-$40K

VIVE Hedge Fund Activity: Q2 2021 in Review

15 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q2 2021, worth a combined $1.89M — down 0.79% from $1.91M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of VIVE and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 5 added.

The largest buyer was State Street, opening a new position worth an estimated $154K. The largest seller was BlackRock, cutting an estimated $154K.

  • 15 institutional investors held VIVEVE MED INC (VIVE) as of Q2 2021, down from 17 in Q1 2021.
  • Funds reported $1.89M of VIVEVE MED INC stock for Q2 2021, down 0.79% quarter-over-quarter.
  • 3 funds opened new VIVEVE MED INC positions in Q2 2021 and 5 closed out, a net change of -2 holders.
  • The largest VIVEVE MED INC buyer in Q2 2021 was State Street, an estimated $154K added.
  • The largest VIVEVE MED INC seller in Q2 2021 was BlackRock, an estimated $154K sold.

Based on aggregated 13F filings for Q2 2021.